You are here: Industry Insights > SARS-CoV-2

News List

Medicago announces production of a viable vaccine candidate for COVID-19 expresspharma
March 27, 2020
The biopharma successfully produced Virus-Like Particles (VLP) of the coronavirus in just 20 days using proprietary plant-based technology Medicago’s platform can produce both vaccine and antibody candidates against COVID-19 disease.
‘Nearly 70 drugs that may be effective against coronavirus identified’ expresspharma
March 27, 2020
An international team, including scientists of Indian origin, has identified 69 drugs and experimental compounds which may be effective in treating COVID-19.
Singapore modelling study estimates impact of physical distancing on reducing spread of COVID-19 worldpharmanews
March 26, 2020
A new modelling study conducted in a simulated Singapore setting has estimated that a combined approach of physical distancing [2] interventions ...
Mesa Biotech Receives Emergency Use Authorization for 30 Minute COVID-19 Test americanpharmaceuticalreview
March 26, 2020
Mesa Biotech announced it has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA) for its Accula™ SARS-CoV-2 Test.
Cepheid Receives Emergency Use Authorization for Rapid SARS-CoV-2 Test americanpharmaceuticalreview
March 25, 2020
Cepheid has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA) for Xpert® Xpress SARS-CoV-2.
CTK Biotech Launches Test kits for COVID-19 americanpharmaceuticalreview
March 24, 2020
CTK has launched two diagnostic tests for this virus, both a real time PCR based nucleic acid detection kit and a serological rapid screening test.
COVID-19 Update: FDA Issues EUA for Point of Care Diagnostic contractpharma
March 24, 2020
First emergency use authorization for a point-of-care COVID-19 diagnostic for the Cepheid Xpert Xpress SARS-CoV-2 test.
Eurofins Expands COVID-19 Testing in Europe and Brazil contractpharma
March 23, 2020
Global testing and lab services provider Eurofins, said, in addition to the U.S and Germany, it is now offering testing for detection of SARS-CoV-2 in France, Spain ...
Mesa Biotech to Receive Funding from US Health and Human Services for Development of a 30 minute Molecular (PCR) Point-of-Care SARS-CoV-2 Test prnewswire
March 20, 2020
Mesa Biotech Inc., a privately-held, molecular diagnostic company has developed an affordable, 30 minute sample-to-answer molecular testing platform designed for point-of-care (POC) infectious disease diagnosis.
Abbott's RealTime SARS-CoV-2 Test Receives EUA contractpharma
March 20, 2020
System uses polymerase chain reaction (PCR) technology and has the ability to run high volumes of up to 470 tests in 24 hours.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 61 62 Next page